Virtual Library

Start Your Search

Filter Results:

Show Only Available Presentations

  • +

    P45 - Novel Therapeutics and Targeted Therapies - ALK/ROS1/MET

    • Type: Posters
    • Track: Novel Therapeutics and Targeted Therapies
    • Presentations: 18
    • Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
    • +

      P45.01 - Therapeutic effectiveness of Lorlatinib After Alectinib in Japanese Patients With ALK-Positive NSCLC in Real-World

      00:00 - 00:00  |  Presenter: Yasushi Goto

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P45.04 - Phase II Study of Brigatinib in ROS1 Positive Non-Small Cell Lung Cancer (NSCLC) Patients Previously Treated with Crizotinib: Barossa Cohort 2

      00:00 - 00:00  |  Presenter: Jun Sakakibara-Konishi

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P47 - Novel Therapeutics and Targeted Therapies - Clinical Trial in Progress

    • Type: Posters
    • Track: Novel Therapeutics and Targeted Therapies
    • Presentations: 18
    • Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
    • +

      P47.04 - TROPION-Lung02: Datopotamab Deruxtecan (Dato-DXd) Plus Pembrolizumab and Platinum-Based Chemotherapy in Advanced NSCLC

      00:00 - 00:00  |  Presenter: Benjamin Levy

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    OA17 - Multidisciplinary Care of Thoracic Oncology Patients During COVID-19 Pandemic

    • Type: Oral
    • Track: Nursing and Allied Health Professionals
    • Presentations: 6
  • +

    ES13 - Ethics, Costs, and Regulation of Lung Cancer*

    • Type: Education Session
    • Track: Health Services Research/Health Economics
    • Presentations: 7
    *Full-length Educational talk will be available as pre-release content as of September 1. The Live Day Educational Sessions will feature brief summaries and extended live discussion with the presenters. Delegates are encouraged to watch the pre-released content prior to watching the live Educational Sessions.
    • Moderators:Bishal Gyawali
    • Coordinates: 9/14/2021, 17:30 - 18:05, Program Auditorium
    • +

      ES13.01 - Immunotherapy Forever? Ideal Duration and Opportunities for De-escalation of Treatment in Lung Cancer Immunotherapy

      17:30 - 17:32  |  Presenter: Yasushi Goto

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.